He holds an MD from the Complutense University of Madrid and completed training in internal medicine and medical oncology at Thomas Jefferson University. His laboratory focuses on metabolic interactions between cancer and stromal cells. He also conducts clinical trials on drugs that alter metabolic interactions between cancer cells and the microenvironment.